Vestmark Advisory Solutions’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.21M Sell
92,156
-6,564
-7% -$530K 0.07% 300
2026
Q1
$8.55M Buy
98,720
+18,628
+23% +$1.78M 0.09% 221
2025
Q4
$7.69M Buy
80,092
+62,433
+354% +$6.06M 0.1% 205
2025
Q3
$1.68M Buy
17,659
+1,592
+10% +$146K 0.03% 440
2025
Q2
$1.4M Buy
16,067
+7,321
+84% +$621K 0.02% 436
2025
Q1
$786K Buy
8,746
+4,338
+98% +$388K 0.02% 441
2024
Q4
$352K Buy
4,408
+1,095
+33% +$94.8K 0.01% 466
2024
Q3
$298K Buy
3,313
+252
+8% +$21.2K 0.01% 455
2024
Q2
$241K Buy
3,061
+85
+3% +$6.97K 0.01% 493
2024
Q1
$259K Buy
+2,976
New +$254K 0.01% 469
2023
Q4
Sell
-6,151
Closed -$482K 523
2023
Q3
$482K Sell
6,151
-82,850
-93% -$6.94M 0.04% 299
2023
Q2
$7.84M Sell
89,001
-3,849
-4% -$331K 0.3% 81
2023
Q1
$7.49M Buy
92,850
+7,978
+9% +$650K 0.32% 66
2022
Q4
$6.6M Buy
84,872
+4,110
+5% +$333K 0.32% 60
2022
Q3
$6.52M Buy
80,762
+12,005
+17% +$1.08M 0.36% 54
2022
Q2
$6.17M Buy
68,757
+4,777
+7% +$484K 0.35% 56
2022
Q1
$7.1M Buy
63,980
+6,444
+11% +$681K 0.4% 44
2021
Q4
$5.95M Buy
57,536
+4,990
+9% +$578K 0.34% 63
2021
Q3
$6.59M Buy
52,546
+6,118
+13% +$792K 0.45% 37
2021
Q2
$5.76M Buy
46,428
+2,481
+6% +$312K 0.41% 43
2021
Q1
$5.19M Buy
43,947
+1,174
+3% +$138K 0.46% 36
2020
Q4
$5.01M Sell
42,773
-1,834
-4% -$202K 0.56% 31
2020
Q3
$4.64M Sell
44,607
-165
-0.4% -$16.6K 0.62% 28
2020
Q2
$4.11M Buy
44,772
+2,096
+5% +$201K 0.64% 30
2020
Q1
$3.85M Buy
42,676
+4,477
+12% +$476K 0.75% 22
2019
Q4
$4.33M Sell
38,199
-170
-0.4% -$18.7K 0.89% 24
2019
Q3
$4.17M Sell
38,369
-1,057
-3% -$110K 0.68% 24
2019
Q2
$3.84M Sell
39,426
-4,626
-11% -$422K 0.66% 27
2019
Q1
$4.01M Buy
+44,052
New +$3.94M 0.72% 22

Other funds holding MDT

Vestmark Advisory Solutions's MDT Position: Q2 2026 in Review

Vestmark Advisory Solutions reduced its Medtronic (MDT) stake by 6.6% in Q2 2026, selling an estimated $530K and leaving 92,156 shares worth $7.21M. The position accounts for 0.07% of the portfolio, ranked #300.

Vestmark Advisory Solutions first reported a position in MDT in Q1 2019 and has held it in 29 quarters since. The position peaked at $8.55M in Q1 2026. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Vestmark Advisory Solutions held 92,156 shares of Medtronic worth $7.21M as of Q2 2026.
  • Vestmark Advisory Solutions sold 6,564 Medtronic shares in Q2 2026, an estimated $530K.
  • Medtronic made up 0.07% of Vestmark Advisory Solutions's portfolio in Q2 2026, its #300 holding.
  • Vestmark Advisory Solutions first reported a position in Medtronic in Q1 2019 and has held it in 29 quarters since.
  • Vestmark Advisory Solutions's Medtronic position peaked at $8.55M in Q1 2026.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Vestmark Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.